Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testosterone Undecanoate for Fatty Liver in Hypogonadal Men with T2DM (Test2Func)
NCT03851627Phase 4Recruiting
- Sponsor
- Alexandra Kautzky-Willer
- Start
- Jan 2022
- Primary completion
- Sep 2028
- Modality
- Hormone, Biologic
- Countries
- 1
01
Overview
A Phase 4 trial of testosterone undecanoate in Hypogonadism, sponsored by Alexandra Kautzky-Willer. Started Jan 2022; status: recruiting.
02
Drugs
testosterone undecanoate
03
Conditions
Hypogonadism
Beyond the preview
Go deeper on NCT03851627.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03851627.